CD274 and melanoma: Newer targets, like programmed death ligand-1 (PDL1) expression and cytotoxic T lymphocyte antigen-4, have been reported in SCLC and melanoma, whereas PDL-1 has been observed to be an independent prognostic marker in NETs [20,205,206,207].